Mark D. Anderson, MD
Associate Professor
Department:
SOM-Neurology
Email:
manderson4@umc.edu
Work Phone:
(601) 984-5500
Biography
Mark D. Anderson, MD is an associate professor in the department of Neurology at the University of Mississippi medical center. He is board certified in Neurology by the American Board of Psychiatry and Neurology and certified in Neuro-Oncology by the United Council of Neurologic Subspecialties. His research and clinical interests are in the treatment of central nervous system tumors and complications related to cancer and serves on committees for the UMC cancer center and research institute. He received his medical degree from the University of Alabama, Birmingham and completed residency training in Neurology at Vanderbilt University. A fellowship in Neuro-Oncology was completed at the University of Texas MD Anderson Cancer Center in Houston, Tx.
Education
| University of Alabama-Birmingham, MD, Medicine | 2007 |
| University of Miami, BS, Biomedical Engineering | 2003 |
| University of Miami, MS, Biomedical Engineering | 2003 |
| The University of Texas M.D. Anderson Cancer Center, MD, Neuro-Oncology | |
| Vanderbilt University, MD, Neurology | |
| Vanderbilt University, MD, Internal Medicine |
Specialty Certification Licensure
| Certification, Neurology | 09/2011 - Present |
| Certification, Neuro-Oncology | 09/2013 - Present |
| Licensure, Mississippi Medical License | 07/2013 - 06/2015 |
Current Positions
| Assistant Professor, School of Medicine, Department of Neurology | 08/2013 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Sponsored Program Funding
| Extramural, Toward Changing Glioblastoma Outcomes: Targeted drug delivery of an inhibitory biopolymer in conjunction with systemic chemotherapy, NCI | 07/2018 - 06/2020 |
Publications
in press/awaiting publication | |
| Sharma A, Grill M, Spritzer S, Leis AA, Anderson MD, Vig P, Porter A Malignant Glial Neuronal Tumors After West Nile Virus Neuroinvasive Disease in press | 2018 |
| Majd N, Metrus N, Santos Pinheiro F, Trevino C, Fuller G, Huse J, Chung C, Ketonen L, Anderson M, Penas-Prado M RBM10 Truncation in Astroblastoma in a Patient with History of Mandibular Ameloblastoma: A case report in press | 2018 |
Letter | |
| Anderson MD, Raghunathan A, Gilbert MR, Textiloma resembling anaplastic progression of an isocitrate dehydrogenase 1 (IDH1) mutant, low grade glioma. Journal of neuro-oncology, 2013 Feb;111(3):377-9 | 2013 |
| Anderson MD, Abel TW, Moots PL, Re-evaluation of nondiagnostic biopsies of suspected low-grade glioma using isocitrate dehydrogenase 1 mutation immunohistochemistry. Neuro-oncology, 2013 Jul;15(7):811-3 | 2013 |
| Anderson MD, Theeler BJ, Penas-Prado M, Groves MD, Yung WK, Bevacizumab use in disseminated choroid plexus papilloma. Journal of neuro-oncology, 2013 Sep;114(2):251-3 | 2013 |
Journal Article | |
| Farkas A, Joyner D, Saad AG, Anderson MD, Khan M Lethal disseminated dysembryoplastic neuroepithelial tumor following West Nile virus: Report of a very unusual combination Radiology Case Reports. June 2018; Volume 13, Issue 3:Pages 555-558 | 2018 |
| Yust-Katz S, Anderson MD, Liu D, Wu J, Yuan Y, Olar A, Fuller GN, Brown PD, de-Groot JF, Clinical and prognostic features of adult patients with gangliogliomas. Neuro-oncology, 2014 Mar;16(3):409-13 | 2014 |
| Anderson MD, Hamza MA, Hess KR, Puduvalli VK, Implications of bevacizumab discontinuation in adults with recurrent glioblastoma. Neuro-oncology, 2014 Jun;16(6):823-8 | 2014 |
| Yust-Katz S, de Groot JF, Liu D, Wu J, Yuan Y, Anderson MD, Conrad CA, Milbourne A, Gilbert MR, Armstrong TS, Pregnancy and glial brain tumors. Neuro-oncology, 2014 Sep;16(9):1289-94 | 2014 |
| Anderson MD, Gilbert MR, Clinical discussion of the management of anaplastic oligodendroglioma/oligoastrocytoma (both codeleted and nondeleted). Journal of the National Comprehensive Cancer Network : JNCCN, 2014 May;12(5):665-72 | 2014 |
| Anderson MD, Tummala S, Herpes myelitis after thoracic spine surgery. Journal of neurosurgery. Spine, 2013 May;18(5):519-23 | 2013 |
| Anderson MD, Gilbert MR, Treatment recommendations for anaplastic oligodendrogliomas that are codeleted. Oncology (Williston Park, N.Y.), 2013 Apr;27(4):315-20, 322 | 2013 |
| Anderson M, Dawson WW, Gonzalez-Martinez J, Curcio CA, Drusen and lipid-filled retinal pigment epithelium cells in a rhesus macula. Veterinary ophthalmology, 2006 May-Jun;9(3):201-7 | |
| Anderson MD, Colen RR, Tremont-Lukats IW, Imaging mimics of primary malignant tumors of the central nervous system (CNS). Current oncology reports, 2014;16(8):399 | |
Abstracts | |
| Anderson MD, Vig P, Leis A Progressive Leptomeningeal Dissemination of a DNT after West Nile Virus Meningoencephalitis Neuro Oncology (2016) 18 (suppl_6): vi169. | 2016 |
| Anderson MD, Jabari D Acute Motor Axonal Neuropathy After Vincristine Infusion in a 21 Year Old. Neuro Oncology (2016) 18 (suppl 6): vi141 | 2016 |
| Lee M, Walsh K, Rey-Dios R, Anderson MD Progressive multifocal leukoencephalopathy mimicking high grade glioma in an immunocompetent patient: A case report. Neuro Oncology (2014) 16 (suppl 5): v149-v150. | 2014 |
Book Chapter | |
| Anderson MD, Misulis K Neuro-Oncology Hospital Neurology. Oxford University Press, 2017 | 2017 |
| Anderson MD, Moots PL Progressive Multifocal Leukoencephalopathy 5-Minute Neurology Consult. Wolters Kluwer, Philadelphia, PA, 2012 | |
Presentations
| State/Local Invited Seminars/Lectures, Overview of primary brain tumors, Cancer Registrars, UMMC Jackson Medical Mall | 04/2018 |
| State/Local Invited Seminars/Lectures, Review of ASCO - CNS tumors, UMMC, UMMC Jackson Medical Mall | 08/2016 |
| State/Local Invited Seminars/Lectures, Overview of primary brain tumors, Cancer Registrars, UMMC Jackson Medical Mall | 04/2016 |
| State/Local Invited Seminars/Lectures, Updates in Glioma therapy, Mississippi Neurosurgical Society, Flowood, MS | 01/2016 |
| State/Local Invited Seminars/Lectures, Review of ASCO: CNS tumors, UMMC, UMMC Jackson Medical Mall | 08/2015 |
Professional Membership and Service
| Society of Neuro-Oncology, Member | 2013 - Present |
| American Society of Clinical Oncology, Member | 2012 - Present |
| American Academy of Neurology, Member | 2008 - Present |
Committee Service
| Cancer Institute – Clinical Leadership Committee, Neuro-Oncology, Member | 2018 - Present |
| Multidisciplinary Tumor Board - CNS tumors, Co-Chair | 2015 - Present |
| Clinical Cancer Committee, Member | 2014 - Present |
| Cancer Institute Protocol Review Committee, Member | 2014 - Present |
| UMMC Ambulatory Workgroup - Quality Subcommittee, Member | 2014 - 2016 |
| Neurology Residency Program Review, Member |
Community Service
| Radio Program Interview, "Good Things" with Rebecca Turner, Interviewee | 11/2017 - 11/2017 |
Other Service
| Journal of the NCCN | 2016 - Present |
| Annals of Neurology | 2015 - Present |
| Journal of the Neurological Sciences | 2014 - Present |
Teaching Experience
| Fellow, Lecture, Lecturer, Treatment of CNS tumors | Annual 2017 |
| Medicine, Lecture, Lecturer, M2 Pharmacology | Fall 2017 - 2017 |
| NA, Resident, Lecture, Lecturer, Neuro-Oncology | Annual 2014 |
Residency Training
| Neurology, Advisor | 2018 - Present |